New England Journal of Medicine Publishes Data from Phase 3 Studies Demonstrating Oveporexton (ORZEYFUL) Improved the Full Range of Narcolepsy Type 1 Symptoms and Quality of Life

Takeda (TSE:4502/NYSE:TAK) announced that the New England Journal of Medicine published results from two Phase 3 studies evaluating oveporexton (ORZEYFUL), an oral orexin receptor 2 (OX2R) agonist, in people with narcolepsy type 1 (NT1).1Oveporexton is the first and...
Anglais

CoreTrust Expands International Presence, Extends Global Procurement Platform Across Europe

CoreTrust, a premier group purchasing organization (GPO) with more than 20 years of leveraging data-driven procurement intelligence and $7 billion in aggregated spend, today announced the expansion of CoreTrust Europe and its procurement platform to the United Kingdom and key European markets, including France, Germany, Ireland, the Netherlands, Sweden, and Switzerland. While members can enroll when headquartered in these seven markets, CoreTrust’s supplier partners deliver negotiated coverage that reaches members well beyond them. This strategic international expansion answers direct demand from CoreTrust’s private equity partners and multinational members to extend the company’s proven model into...
Anglais

Bracco Expands BubbleGen Cell Selection with CD3+ T Cell Isolation Kit

Bracco Imaging, a global pharmaceutical company that develops, manufactures, and markets innovative healthcare solutions, today announced the expansion of its BubbleGen™cell selection portfolio with the launch of the BubbleGen CD3+ T Cell Selection Kit. The kit, built on Bracco's microbubble technology, can enable new cell therapy workflows, including a highly scalable and cost-effective approach to manufacturing CAR-T cell therapies. This marks the first of multiple planned expansions of the BubbleGen family of...
Anglais
09/09/2026 14:00
Ennov Appoints Oxana Pickeral as Chief Executive Officer

Ennov (the “Company”), a global provider of a unified compliance platform that streamlines regulatory, clinical, quality, and pharmacovigilance operations for life sciences and healthcare companies, today announced the appointment of Dr. Oxana Pickeral as Chief Executive Officer. Founder and outgoing CEO, Olivier Pâris, will join Ennov’s Board of Directors and continue to support the company as a Strategic Advisor. Dr. Pickeral has spent her career at the forefront of innovation in life scien...

09/18/2026 00:00
ISG Announces 2026 ISG Women in Digital Awards Winners for Asia Pacific

Information Services Group (ISG) (Nasdaq: III), a global AI-centered technology research and advisory firm, today announced the winners of the ISG Women in Digital Awards program for Asia Pacific, recognizing women and their achievements in technology roles. At a live, virtual award ceremony the evening of September 17, leaders with RiskSpan, Spark New Zealand, HCLTech, Wipro, Hamsa AI Labs and Microland Limited were honored as gold winners in six categories. Silver and bronze winners were al...

09/01/2026 20:36
Meraki Capital Launches Tessero Across Six European Markets Following Landmark Hays Acquisition

Meraki Capital has launched Tessero, a new European specialist recruitment group created from the six former Hays plc businesses it acquired earlier this summer. Launching simultaneously across Sweden, Denmark, Hungary, Romania, Luxembourg and Czechia, Tessero brings six established recruitment businesses together under one independent European brand, creating an international platform with experienced teams, existing clients and active candidate networks from day one. The launch follows on...